Analytical R&D (ARD) Development and Quality Control

Regulatory-compliant and phase-appropriate (discovery, preclinical, clinical and commercial) analytical method development and quality control strategy

We have a dedicated and professional ARD team with over a decade of experiences and a successful track record in developing and validating compliant and clinical phase-appropriate analytical methods. Our services include analytical method development and optimization, analytical method transfer and validation, stability studies, reference standards characterization, release testing, quality control strategy development etc.

How does it work?

Our dedicated ARD team has a thorough understanding of the latest regulatory requirements, relevant chemistry and analytical knowledge which are essential in developing efficient, accurate and robust analytical methods.

The ARD team interacts closely with PRD team to understand process requirements in order to  quickly develop appropriate analytical methods for monitoring reactions and final product testing. Our team has extensive experience and knowledge in developing analytical methods for chiral compounds, as well as in developing methods for trace residue detection such as genotoxic impurities (GTIs) and nitrosamine detection.

The analytical methods are validated by a team under GMP with QA supervision and in accordance with the appropriate phase requirements and ICH norms. During the validation of the analytical method, the team performs all activities as required by the client, including the review and approval of the validation protocol and report.

Our ARD service includes but are not limited to:

  • Analytical method development and validation
  • Analytical method transfer
  • Stability studies
  • Reference standard characterization
  • Preparation of impurities and structural identification
  • Method development and method validation for GTIs
  • Product release testing
  • Characterization of physicochemical properties
  • Microbiological testing
  • Design quality control strategy (impurity control, quality study for IND/NDA filing, QRA, QbD study etc)
  • Method development report in accordance with IND/NDA requirements


Partial list of key analytical instruments we use:

  • Chromatography: HPLC, UPLC, GC, IC, SFC, LC-CAD, LC-ELSD, PREP-LC
  • Mass spectrometry: LCMS, GCMS, HRMS
  • Identification: FT-IR, LCMS, NMR, HRMS
  • Elemental impurities: ICP-OES, ICP-MS
  • General testing: KF, Titration, UV, LOD, cKF
  • Solid state testing: XRPD, DSC, TGA, DVS, PSD

Why Bellen ?

  • Experienced team, well versed in relevant global guidelines and customers expectations
  • Rich experiences in analytical method development and quality standards development for APIs.
  • Our QC team strictly adheres to the appropriate regulatory requirements and generates reliable data.
  • Analytical instruments are set within chemistry labs to provide chemists with immediate access to analytical data
  • We apply the latest analytical techniques to support analytical development when appropriate
  • We have a common process to improve the efficiency of analytical method development
  • We continue introducing advanced instruments and technical capabilities
  • State-of-the-art equipment, tools and techniques available in our analytical labs

Other Services

Fill out the form to contact us

Customer Service and Business Inquiry
Join Bellen
Investor Relations
  • Submit
  • Submit
  • Submit